Previous Article | Next Article ![]()
Infection and Immunity, December 2000, p. 6685-6690, Vol. 68, No. 12
Department of Medical Microbiology, Academic
Medical Center, University of Amsterdam, and Reference Laboratory for
Bacterial Meningitis, University of Amsterdam/RIVM, 1100 DE Amsterdam,
The Netherlands
Received 6 July 2000/Returned for modification 14 August
2000/Accepted 25 September 2000
Previously, we reported that PorA expression in Neisseria
meningitidis is modulated by variation in the length of the
homopolymeric tract of guanidine residues between the
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Multiple Mechanisms of Phase Variation of PorA in
Neisseria meningitidis
35 and
10
regions of the promoter or by deletion of porA. To reveal
additional mechanisms of variation in PorA expression, the
meningococcal isolates from 41 patients and 19 carriers were studied.
In addition, at least 3 meningococcal isolates from different body
parts of each of 11 patients were analyzed. Sequence analysis of the
porA promoter showed that the spacer between the
35 and
10 regions varies in length between 14 and 24 bp. PorA expression was
observed in strains with a porA promoter spacer of 16 to 24 bp. All but one strain with a porA promoter spacer of 16 to
20 bp and undetectable PorA expression have a homopolymeric tract of 8 or 6 instead of 7 adenine residues in the porA coding
region. The other PorA-negative strain had a single-base-pair deletion
in the coding region. The highest level of PorA expression was observed
in strains with a promoter spacer of 17 or 18 bp. PorA expression was
reduced twofold in strains with a porA promoter spacer of
16 or 19 bp. Strains with a 16-bp promoter spacer with substitutions in
the polyguanidine tract displayed increased levels of PorA expression compared to strains with a homopolymeric tract of guanidine residues in
the porA promoter. In conclusion, meningococci display
multiple mechanisms for varying PorA expression.
*
Corresponding author. Mailing address: Department of
Medical Microbiology, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands. Phone: (31-20) 5664862. Fax: (31-20) 6979271. E-mail:
a.vanderende{at}amc.uva.nl.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|